Kali-Din Tablets (Calidinegase)

Adult dose

Administer 30~150I.U. orally in 3 divided doses per day. Adjust the dose as appropriate according to age and symptoms.

This medication should not be used in patients with bleeding, such as immediately after a cerebral hemorrhage. Additionally, since this product contains lactose, it should not be administered to patients with genetic conditions such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. While using this medication, hypersensitivity reactions such as skin rashes or itching may occur, and if such symptoms appear, the use should be discontinued immediately. Palpitations, which are symptoms of increased heart rate, may occur rarely, so caution is necessary. Gastrointestinal symptoms such as gastric discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, and constipation may also appear. Furthermore, symptoms such as fever, headache, heavy sensation in the head, drowsiness, and fatigue may rarely occur, so the patient's condition should be closely monitored. In the elderly, physical functions may be reduced, so special caution should be exercised when using this medication, including dose adjustment.

• Rash
• itching
• palpitations
• abdominal discomfort
• nausea
• vomiting
• loss of appetite
• upper abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage can help maintain the effectiveness of the medication for a longer period.

Appearance

White round enteric-coated film tablets

Package unit

30 tablets/bottle, 300 tablets/bottle